Glen S Frick

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi Proliferative signaling by store-operated calcium channels opposes colon cancer cell cytostasis induced by bacterial enterotoxins
    Shiva Kazerounian
    Division of Clinical Pharmacology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    J Pharmacol Exp Ther 314:1013-22. 2005
  2. ncbi Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer
    Glen S Frick
    Respiratory and Inflammation Centre of Excellence for Drug Discovery, Discovery Medicine, GlaxoSmithKline, PA, USA
    Expert Rev Mol Diagn 5:701-13. 2005

Collaborators

Detail Information

Publications2

  1. ncbi Proliferative signaling by store-operated calcium channels opposes colon cancer cell cytostasis induced by bacterial enterotoxins
    Shiva Kazerounian
    Division of Clinical Pharmacology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    J Pharmacol Exp Ther 314:1013-22. 2005
    ..They suggest that combining guanylyl cyclase C agonists and SOC inhibitors offers a novel paradigm for cGMP-directed therapy and prevention for colorectal tumors...
  2. ncbi Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer
    Glen S Frick
    Respiratory and Inflammation Centre of Excellence for Drug Discovery, Discovery Medicine, GlaxoSmithKline, PA, USA
    Expert Rev Mol Diagn 5:701-13. 2005
    ....